CClinicalTrials.gg
Status unknownNCT03261986Updated Mar 17, 2020

A Prospective RSA and Clinical Evaluation of the Trident II Acetabular Cup

An interventional study of Radiostereometric Analysis and total hip arthroplasty with RSA bead implantation in Total Hip Arthroplasty and Acetabular Cup, sponsored by Midwest Orthopaedics at Rush. Status unknown at 1 site in United States. Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2020-03-17.

Sponsored by Midwest Orthopaedics at Rush · Not applicable, Interventional, and Other

The sponsor has not verified this record recently (last verified Mar 2020), so the status shown — last known as Active, not recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Not applicable
Ages
18 Years to 85 Years
Sex
All
01

Study summary

The objective of this study is to use radiostereometric analysis (RSA) and clinical outcome measures to evaluate early post-operative implant stability and the clinical performance of Stryker's Trident II Acetabular Cup.

Read the detailed description

The proposed study is a prospective evaluation of data from patients undergoing primary total hip arthroplasty using the Trident II acetabular cup. Fifty patients will be recruited for this study. All patients that qualify for the study per the inclusion-exclusion criteria and provide written informed consent will receive the Trident II acetabular cup and RSA beads. Implant stability, through RSA, will be measured throughout the first two postoperative (post-op) years per the following schedule: immediate post-op and 6 weeks, 3 months, 6 months, 1 year, and 2 years following surgery. Patients will be discharged and seen for follow-up assessments as per standard of care. Adverse events that are related to the index joint will be collected. Health outcome questionnaires will be collected. The health outcome questionnaires will include: EQ-5D, HOOS JR and Harris Hip Score. Health outcome questionnaires will be completed pre-operatively and again at 6 weeks, 3 months, 6 months, 1 year and 2 years following surgery. Conventional x-ray analysis will be performed pre-operatively and again at 6 weeks, 1 year and 2 years following surgery.

02

Conditions studied

  • Total Hip Arthroplasty
  • Acetabular Cup

Keywords

  • Trident
  • RSA
  • THA
03

Who can participate

Ages eligible
18 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Symptomatic arthritis of the hip indicating surgical intervention
  2. Scheduled to undergo a primary total hip arthroplasty
  3. Patient is a candidate for the Trident II acetabular cup in accordance with product labeling -

Exclusion criteria

Exclusion Criteria:

  1. Patients less than 18 years of age, or older than 85 years of age.
  2. Severe hip dysplasia (Crowe Type III or IV) in the affected hip
  3. History of congenital dislocation
  4. Prior arthroplasty of the affected hip
  5. Active or prior infection of the affected hip
  6. Morbid obesity (BMI > 40)
  7. Medical condition precluding major surgery
  8. Severe osteoporosis
  9. Neuromuscular impairment
  10. Patients with known allergy to metals
  11. Pregnancy
  12. Patients on dialysis or creatinine > 2.0
  13. Patient is immuno-suppressed -
04

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
50 participants (actual)

Study arms

  • Other
    Trident II acetabular cup

    Subjects receive the Trident II acetabular cup and RSA beads and undergo a series of post-operative RSA exams.

    Radiation: Radiostereometric Analysis · Procedure: total hip arthroplasty with RSA bead implantation

Interventions

  • RadiationRadiostereometric Analysis

    RSA exams of the operative hip are received post-op day 1, and at 6 weeks, 3 months, 6 months, 1 year and 2 years following surgery

  • Proceduretotal hip arthroplasty with RSA bead implantation

    Patients receive RSA beads inserted into the bone surrounding the Trident II implant.

05

What researchers measure

Primary outcomes

  1. Does the Trident II Cup achieve acceptable fixation to the underlying bone?

    The Trident II Cup proximal migration will be assessed. Migration of less than 0.2mm at 2 years and without continuous migration between post-operative year 1 and 2 will indicate acceptable fixation.

    Time frame: 3 years

Secondary outcomes

  1. What are the migration patterns of the Trident II acetabular cup over the first two post-operative years?

    Migration patterns will be assessed using RSA analysis.

    Time frame: 3 years

  2. Is there a significant difference in health status and functional outcome before and after hip arthroplasty using Trident II Cup?

    The health status and functional outcome will be assessed via Harris Hip Score.

    Time frame: 3 years

  3. Is there a significant difference in health status and functional outcome before and after hip arthroplasty using Trident II Cup?

    The health status and functional outcome will be assessed via EQ-5D.

    Time frame: 3 years

  4. Is there a correlation between radiolucent lines measured by Charnley-DeLee zone analysis and migration characteristics using RSA?

    X-ray radiographs will be taken at pre-op, 6 weeks, 1 year and 2 year appointments. It may take up to 3 years after study start for all patients to reach the 2 year visit mark, depending on how long enrollment takes.

    Time frame: 3 years

  5. Can inducible displacements measured at 1 year post-operative distinguish patients identified by RSA measurements as having inadequate fixation?

    Inducible displacements will be measured using RSA exams at the 1 year follow-up. It may take up to 2 years after study start for all patients to reach the 1 year visit mark, depending on how long enrollment takes.

    Time frame: 2 years

06

Study locations

1 site
  • Midwest Orthopaedics at Rush
    Naperville, Illinois 60563, United States
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT03261986
Lead sponsor
Midwest Orthopaedics at Rush
Responsible party
Sponsor
First posted
Aug 25, 2017
Start date
Jun 9, 2017
Primary completion
Oct 9, 2020 (estimated)
Completion
Feb 9, 2022 (estimated)
Last update
Mar 17, 2020

Study contacts

Scott Sporer, MD
principal investigator · Midwest Orthopaedics at Rush

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion